Heparanase, a key target for gene therapy against human malignancies.
Zhang
Youlei
Y
Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, 200438, China. zhangylei111@hotmail.com
Wang
Yi
Y
Fu
Zhiren
Z
Shen
Feng
F
D020533:Angiogenesis Inhibitors; D001485:Basement Membrane / Q000201:enzymology; D018450:Disease Progression; D005109:Extracellular Matrix / Q000201:enzymology; D015971:Gene Expression Regulation, Enzymologic; D015972:Gene Expression Regulation, Neoplastic; D020868:Gene Silencing; D015316:Genetic Therapy; D005966:Glucuronidase / Q000037:antagonists & inhibitors / Q000096:biosynthesis* / Q000235:genetics; D006801:Humans; D009361:Neoplasm Invasiveness / Q000235:genetics; D009362:Neoplasm Metastasis / Q000235:genetics; D009369:Neoplasms / Q000201:enzymology / Q000235:genetics / Q000628:therapy; D009389:Neovascularization, Pathologic / Q000201:enzymology / Q000235:genetics; D034741:RNA, Small Interfering / Q000008:administration & dosage / Q000378:metabolism; D000099175:Heparanase
D020533:Angiogenesis Inhibitors; D005966:Glucuronidase; D034741:RNA, Small Interfering; D000099175:Heparanase